Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Discover Oncology|January 15, 2026
Novel therapeutic potential of the PARP inhibitor talazoparib in synovial sarcoma and its combined effect with ATR inhibitorNoritaka Honda, Hirokazu Taniguchi, Sawana Ono, et al.
Journal of Clinical Medicine|April 11, 2020
Prediction of Anti-Cancer Drug-Induced Pneumonia in Lung Cancer Patients: Novel High-Resolution Computed Tomography Fibrosis ScoringHiroshi Gyotoku, Hiroyuki Yamaguchi, Hiroshi Ishimoto, et al.
Thoracic Cancer|May 29, 2020
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II studyTakaya Ikeda, Shinnosuke Takemoto, Hiroaki Senju, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2020
[Trends in Outpatient Chemotherapy for Thoracic Oncology]Minoru Fukuda, Hiroyuki Yamaguchi, Shinnosuke Takemoto, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2019
Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancerMidori Shimada, Hiroyuki Yamaguchi, Minoru Fukuda, et al.
Lung Cancer Management|June 7, 2023
Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsyShinnosuke Takemoto, Mutsumi Ozasa, Remi Mizuta, et al.
Thoracic Cancer|November 20, 2020
Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutationYosuke Dotsu, Minoru Fukuda, Noritaka Honda, et al.
Thoracic Cancer|February 19, 2021
Remarkable response to pembrolizumab with platinum-doublet in PD-L1-low pulmonary sarcomatoid carcinoma: A case reportHirokazu Taniguchi, Shinnosuke Takemoto, Mutsumi Ozasa, et al.
Lung Cancer (Amsterdam, Netherlands)|July 2, 2025
Phase III study of ramucirumab plus docetaxel versus atezolizumab for previously treated PD-L1 low or negative advanced non-small-cell lung cancer: WJOG10317L studyYoshitaka Zenke, Seiji Niho, Yukihiro Toi, et al.
Thoracic Cancer|July 13, 2021
Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysisShinnosuke Takemoto, Kazumasa Akagi, Sawana Ono, et al.
Pageof 4